Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications.
Mongkolpathumrat P, Pikwong F, Phutiyothin C, Srisopar O, Chouyratchakarn W, Unnajak S, Nernpermpisooth N, Kumphune S. Mongkolpathumrat P, et al. Heliyon. 2024 Jan 17;10(2):e24550. doi: 10.1016/j.heliyon.2024.e24550. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312697 Free PMC article. Review.
Adeno-associated virus 9 vector-mediated cardiac-selective expression of human secretory leukocyte protease inhibitor attenuates myocardial ischemia/reperfusion injury.
Mongkolpathumrat P, Nernpermpisooth N, Kijtawornrat A, Pikwong F, Chouyratchakarn W, Yodsheewan R, Unajak S, Kumphune S. Mongkolpathumrat P, et al. Front Cardiovasc Med. 2022 Aug 19;9:976083. doi: 10.3389/fcvm.2022.976083. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36061560 Free PMC article.
Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury.
Pikwong F, Phutiyothin C, Chouyratchakarn W, Baipaywad P, Mongkolpathumrat P, Kumphune S. Pikwong F, et al. Among authors: mongkolpathumrat p. Heliyon. 2023 Sep 16;9(9):e20150. doi: 10.1016/j.heliyon.2023.e20150. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809945 Free PMC article.
p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats.
Nokkaew N, Mongkolpathumrat P, Junsiri R, Jindaluang S, Tualamun N, Manphatthanakan N, Saleesee N, Intasang M, Sanit J, Adulyaritthikul P, Kongpol K, Kumphune S, Nernpermpisooth N. Nokkaew N, et al. Among authors: mongkolpathumrat p. Indian J Clin Biochem. 2021 Apr;36(2):228-234. doi: 10.1007/s12291-019-0815-9. Epub 2019 Jan 31. Indian J Clin Biochem. 2021. PMID: 33867715 Free PMC article.
Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats.
Sanit J, Prompunt E, Adulyaritthikul P, Nokkaew N, Mongkolpathumrat P, Kongpol K, Kijtawornrat A, Petchdee S, Barrère-Lemaire S, Kumphune S. Sanit J, et al. Among authors: mongkolpathumrat p. Exp Ther Med. 2019 Sep;18(3):1701-1714. doi: 10.3892/etm.2019.7763. Epub 2019 Jul 10. Exp Ther Med. 2019. PMID: 31410128 Free PMC article.